Changes in plasma cholesterol in mood disorder patients: does treatment make a difference?

Area of Science:

• Psychiatry
• Clinical Chemistry

Background:

• Bipolar disorder and major depressive disorder are associated with altered lipid metabolism.
• Treatment for mood disorders can impact various physiological markers, including cholesterol levels.

Purpose of the Study:

• To investigate the effect of acute treatment for major depressive (MD) and manic/hypomanic (M/HM) episodes on total cholesterol (TC) levels.
• To explore the relationship between changes in TC and psychiatric symptom severity.

Main Methods:

• Patients with acute MD or M/HM episodes were treated with antidepressants, mood stabilizers, or both.
• Clinical symptoms were assessed using the Hamilton Depression Rating Scale (HAM-D), Mania Rating Scale (MMRS), and Hamilton Anxiety Scale (HAM-A).
• Blood samples for TC were collected before treatment and 4 weeks after treatment initiation.

Main Results:

• A statistically significant increase in TC was observed in patients with MD after 4 weeks of treatment.
• A statistically significant decrease in TC was observed in patients with M/HM episodes after 4 weeks of treatment.
• No direct correlation analysis results were provided in the abstract.

Conclusions:

• Treatment for major depressive episodes is associated with increased total cholesterol levels.
• Treatment for manic/hypomanic episodes is associated with decreased total cholesterol levels.
• While statistically significant, the clinical implications of these TC changes warrant further investigation in longer-term studies.